10x Genomics Inc (LTS:0A88)
$ 14.72 0.6324 (4.47%) Market Cap: 1.78 Bil Enterprise Value: 1.46 Bil PE Ratio: 0 PB Ratio: 2.46 GF Score: 60/100

10X Genomics Inc at Stephens Investment Conference Transcript

Nov 14, 2023 / 04:00PM GMT
Release Date Price: $39.78 (+10.07%)
Mason Owen Carrico
Stephens Inc., Research Division - Research Analyst

Thanks, everyone, for joining us. My name is Mason Carrico. I'm the Diagnostics and Genomics analyst at Stephens. Today, we have Justin McAnear and Cassie Corneau of 10x Genomics with us. If at any point, anyone from the audience has questions, feel free to jump in and ask away.

Questions & Answers

Mason Owen Carrico
Stephens Inc., Research Division - Research Analyst

But we'll start with the quarter, beat and raised in a challenging environment. What are some of the key takeaways for investors to keep top of mind from the call?

Justin J. McAnear
10x Genomics, Inc. - CFO

Great. Well, first off, thanks for inviting us today. Very happy to be here today. In thinking about Q3, you're right. It was a solid quarter. We're proud of what the team accomplished this past quarter. As far as key takeaways, here's 3 things that we'd like to convey. The first is that we saw an acceleration of Xenium this quarter. Our approach in prioritizing

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot